Skip to content
Nonprofiteer
← PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC

Form 990 for tax year 2024

Filed by PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC.

Totals

Total revenue
$4,293,133
Total expenses
$4,981,861
Contributions and grants received
$3,705,380
Grants paid
$3,479,307
Program service revenue
$0
Investment income
$587,753
Other revenue
$0
Total assets, end of year
$27,568,119
Total liabilities, end of year
$1,540,685
Net assets or fund balances, end of year
$26,027,434
Program services expenses (Part IX)
$4,405,267
Management and general expenses
$573,269
Fundraising expenses
$3,325
Program service expenses (Part III)
$4,405,267

Program services were 88.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $3,705,380

  • 2f · All other program service revenue

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 3 · Investment income

    total $600,608 · excluded $600,608

  • 6c · Rental income or loss

    real property $0 · personal property $0

  • 7a · Gross sales of assets other than inventory

    securities $9,587,492

  • 7b · Less cost or other basis and sales expenses

    securities $9,600,347

  • 7c · Gain or loss

    securities -$12,855 · other assets $0

  • 7d · Net gain or loss

    total -$12,855 · excluded -$12,855

  • 8c · Net income from fundraising events

    total $0

  • 11d · All other revenue

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 11e · Other revenue, total

    $0

Functional expenses

Part IX, the statement of functional expenses.

  • 2 · Grants to domestic individuals

    total $3,479,307 · program services $3,479,307

  • 5 · Compensation of officers, directors and key employees

    total $587,906 · program services $416,276 · management and general $171,630

  • 7 · Other salaries and wages

    total $334,705 · program services $236,993 · management and general $97,712

  • 8 · Pension plan contributions

    total $72,659 · program services $51,447 · management and general $21,212

  • 9 · Other employee benefits

    total $77,147 · program services $54,625 · management and general $22,522

  • 10 · Payroll taxes

    total $64,246 · program services $45,490 · management and general $18,756

  • 11c · Fees: accounting

    total $35,316 · management and general $35,316

  • 11f · Fees: investment management

    total $22,367 · management and general $22,367

  • 11g · Fees: other

    total $178,693 · program services $33,400 · management and general $145,293 · fundraising $0

  • 12 · Advertising and promotion

    total $8,169 · program services $8,169

  • 13 · Office expenses

    total $946 · program services $680 · management and general $266

  • 14 · Information technology

    total $14,794 · program services $14,436 · management and general $358

  • 17 · Travel

    total $28,332 · program services $14,148 · management and general $14,184

  • 19 · Conferences, conventions and meetings

    total $19,251 · program services $19,251

  • 22 · Depreciation, depletion and amortization

    total $32,726 · program services $23,172 · management and general $9,554

  • 23 · Insurance

    total $10,228 · program services $7,242 · management and general $2,986

  • 24a · Other expenses: DUES/ PUBLICATIONS/ PROJECTS

    total $4,807 · program services $631 · management and general $851 · fundraising $3,325

  • 24b · Other expenses: BANK/ PAYROLL CHARGES

    total $10,262 · management and general $10,262

  • 24e · All other expenses

    total $0 · program services $0 · management and general $0 · fundraising $0

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $1,396,883 · end of year $2,768,034

  • 5 · Loans and receivables from officers and key people

    beginning of year $0 · end of year $0

  • 6 · Loans and receivables from disqualified persons

    end of year $0

  • 9 · Prepaid expenses and deferred charges

    beginning of year $20,886 · end of year $18,563

  • 10a · Land, buildings and equipment: cost or other basis

    $98,178

  • 10b · Land, buildings and equipment: accumulated depreciation

    $38,180

  • 10c · Land, buildings and equipment, net

    beginning of year $92,724 · end of year $59,998

  • 11 · Investments: publicly traded securities

    beginning of year $22,970,816 · end of year $24,721,524

  • 12 · Investments: other securities

    beginning of year $0

  • 13 · Investments: program-related

    beginning of year $0

  • 15 · Other assets

    beginning of year $0 · end of year $0

  • 17 · Accounts payable and accrued expenses

    beginning of year $374,751 · end of year $1,517,703

  • 22 · Loans and payables to officers and key people

    end of year $0

  • 25 · Other liabilities

    beginning of year $29,770 · end of year $22,982

  • 27 · Net assets without donor restrictions

    beginning of year $24,076,788 · end of year $26,027,434

Mission and programs · 2024

Mission

THE PHRMA FOUNDATION WORKS TO IMPROVE PUBLIC HEALTH BY PROACTIVELY INVESTING IN INNOVATIVE RESEARCH, EDUCATION AND VALUE-DRIVEN HEALTH CARE.

Activities or mission (Part I)

THE PHRMA FOUNDATION WORKS TO IMPROVE PUBLIC HEALTH BY PROACTIVELY INVESTING IN INNOVATIVE RESEARCH, EDUCATION AND VALUE DRIVEN HEALTH CARE.

  • DRUG DISCOVERY - SUPPORTS EARLY CAREER RESEARCHERS WHOSE RESEARCH CAN HELP ACCELERATE BIOLOGICAL VALIDATION OF POTENTIAL DRUG TARGETS.

    Expenses $1,270,844 · Grants $1,020,832

  • VALUE ASSESSMENT-HEALTH OUTCOMES RESEARCH - SUPPORTS RESEARCHERS INVESTIGATING CHALLENGES IN EVALUATING THE DELIVERY, SAFETY, EFFECTIVENESS, AND VALUE OF HEALTH CARE INTERVENTIONS.

    Expenses $1,183,448 · Grants $942,224

  • DRUG DELIVERY - SUPPORTS EARLY CAREER RESEARCHERS STUDYING WAYS TO OPTIMIZE DRUG COMPOSITION, DOSAGE, AND DELIVERY TO MAKE TREATMENTS SAFER, MORE EFFECTIVE, AND EASIER TO MANAGE FOR PATIENTS.

    Expenses $1,051,264 · Grants $851,250

  • TRANSLATIONAL MEDICINE - SUPPORTS EARLY CAREER INVESTIGATORS CONDUCTING NOVEL RESEARCH THAT USES THE "BEDSIDE TO BENCH" APPROACH TO ADDRESS UNMET NEEDS IN THE DIAGNOSIS, TREATEMENT, AND PREVENTION OF DISEASE.

    Expenses $675,841 · Grants $540,000

  • OTHER PROGRAMS EXPENSES

    Expenses $223,870 · Grants $125,001

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Andrew Plump MD PhD

    CHAIRMAN

    Total calculated
    $0
    Hours/week
    1

  • Donatello Crocetta

    TREASURER (AS OF 12/24)

    Total calculated
    $0
    Hours/week
    1

  • Iris Loew-Friedrich MD

    TREASURER (THRU 12/24)

    Total calculated
    $0
    Hours/week
    1

  • Aida Habtezion MD Msc Frcp

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Aran Maree Mb Bch Mrcip

    DIRECTOR (THRU 10/24)

    Total calculated
    $0
    Hours/week
    1

  • DANIEL SKOVRONSKY MD PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • George Addona PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • JOHN REED MD PhD

    DIRECTOR (AS OF 12/24)

    Total calculated
    $0
    Hours/week
    1

  • LORI REILLY Esq

    EX OFFICIO MEMBER

    Total calculated
    $0
    Hours/week
    1

  • Maha Radhakrishnan MD

    DIRECTOR (THRU 03/24)

    Total calculated
    $0
    Hours/week
    1

  • Robert Plenge MD PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Amy Miller

    PRESIDENT

    Total calculated
    $5,879
    From this org
    $5,151
    From related orgs
    $0
    Other
    $728
    Hours/week
    37.5

  • Emily Ortman

    SENIOR DIRECTOR

    Total calculated
    $2,576
    From this org
    $1,989
    From related orgs
    $0
    Other
    $587
    Hours/week
    37.5

  • Joanne Westphal

    DIRECTOR

    Total calculated
    $2,151
    From this org
    $1,788
    From related orgs
    $0
    Other
    $363
    Hours/week
    37.5

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Schedule J

Answered yes

  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990
Tax year
2024
Filed
23 June 2025
IRS schema version
2024v5.1
Source object
202501749349301170

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.